← Back to Search

Behavioral Intervention

PMP Integration & Nudge for Opioid Use Disorder (PRINCE Trial)

N/A

Waitlist Available

Led By Ezra Golberstein, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PRINCE Trial Summary

This trial will test whether EHR-based decision support tools, informed by behavioral economics principles, can effectively nudge PCPs towards more guideline-concordant pain treatment and opioid prescribing decisions.

Eligible Conditions

Opioid Use Disorder
Opioid Addiction

PRINCE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Opioid Prescription Rate

Secondary outcome measures

Opioid Prescription Length

Opioid Prescription MME

Rate of Non-Opioid Treatment Prescription

PRINCE Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: PMP Integration & NudgeExperimental Treatment1 Intervention

Clinics in this arm will receive the Prescription Drug Monitoring (PMP) Integration & Nudge intervention.

Group II: Choice Architecture Nudge + PMP Integration & NudgeExperimental Treatment2 Interventions

Clinics in this arm will receive both the choice architecture nudge and prescription drug monitoring (PMP) integration & nudge interventions.

Group III: Choice Architecture NudgeExperimental Treatment1 Intervention

Clinics in this arm will receive the choice architecture nudge intervention.

Group IV: Care as UsualActive Control1 Intervention

Clinics assigned to this arm will continue to care for the patients as usual in regards to opioid prescribing.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PMP Integration & Nudge

2020

N/A

~1270

Choice Architecture Nudge

2020

N/A

~1270

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,008 Total Patients Enrolled

University of MinnesotaLead Sponsor

1,381 Previous Clinical Trials

1,550,653 Total Patients Enrolled

Ezra Golberstein, PhDPrincipal InvestigatorUniversity of Minnesota

2 Previous Clinical Trials

1,262 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this trial still available?

"This clinical trial, which was initially published in late August 2020, is currently recruiting participants according to information on the clinicaltrials.gov website. The posting has been updated as recently as early August 2022."

Answered by AI

How many volunteers are involved in this medical experiment?

"Affirmative. Records posted on clinicaltrials.gov suggest that this research programme is still searching for participants, having been initially announced on August 26th 2020 and most recently updated in August 2022. 631 patients are required to be recruited from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population

2020. "PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04601493.